Latest Regulatory Compliance News

Metal Bank Limited addresses ASX concerns over recent share price volatility, confirming a pending Mineral Resource Estimate announcement and recent strategic moves as key drivers.

NEXTDC has responded to ASX concerns over early media disclosures about its $7 billion OpenAI data centre deal, affirming compliance with continuous disclosure rules and downplaying price sensitivity.

Lycopodium Limited has addressed ASX concerns over delayed director interest disclosures, attributing the lapse to an administrative oversight while reaffirming its compliance policies.

RMA Global Limited has firmly denied allegations of selective disclosure following a December 4 webinar that coincided with a notable share price rise. The company insists no new price sensitive information was shared beyond prior ASX announcements.

Alicanto Minerals has acknowledged a late filing of a director’s interest notice, attributing it to an administrative oversight. The ASX has queried the delay, prompting the company to review its disclosure procedures.

Miramar Resources has completed its Tranche 1 share placement and secured a further $205,000 commitment from a director for Tranche 2, pending shareholder approval in early 2026.

Amplitude Energy has addressed an ASX query regarding the delayed filing of a director’s interest change, attributing it to an administrative oversight while affirming its compliance framework.

Rhythm Biosciences has begun commercialising ColoSTAT®, its blood-based colorectal cancer diagnostic test, following an updated ISO15189, 2022 accreditation. The test offers a new option for symptomatic patients where stool-based screening is unsuitable.

Minbos Resources has updated the schedule for its Placement and Share Purchase Plan, delaying the SPP opening to mid-December with completion expected by early February 2026.

Locate Technologies Limited will be suspended from ASX trading following court approval of a scheme making Locate NZ the new parent company.

Elixir Energy Limited has responded to ASX concerns over a delayed director interest disclosure, attributing the lapse to administrative changes and reaffirming its compliance protocols.

Robex Resources and Predictive Discovery have amended their arrangement agreement, reducing the exchange ratio and delaying the shareholder meeting to late December. Major shareholders have recommitted to support the deal, which awaits court approval.